Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Tamsulosin increases the risk of floppy iris during eye surgery.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

A man had a rare stroke possibly due to taking finasteride, which might have increased his hormone levels causing a blood clot. His memory loss didn't fully recover even after stopping the medication.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

Finasteride and minoxidil may increase stroke risk by affecting blood clotting and blood pressure.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.

Children taking higher doses of valproic acid had lower biotinidase activity, which may lead to biotin deficiency, but biotin supplements could help.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

Baricitinib helps treat severe hair loss in people over 65.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.